H. Lundbeck A/S (CPH:HLUN.B)
38.10
+0.32 (0.85%)
At close: Mar 9, 2026
H. Lundbeck Market Cap
H. Lundbeck has a market cap or net worth of 36.71 billion as of March 9, 2026. Its market cap has decreased by -8.78% in one year.
Market Cap
36.71B
Enterprise Value
44.93B
Revenue
24.63B
Ranking
n/a
PE Ratio
11.74
Stock Price
38.10
Market Cap Chart
Since June 10, 2022, H. Lundbeck's market cap has increased from 32.08B to 36.71B, an increase of 14.41%. That is a compound annual growth rate of 3.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 36.71B | -11.33% |
| Dec 30, 2025 | 41.40B | 5.03% |
| Dec 30, 2024 | 39.42B | 24.27% |
| Dec 29, 2023 | 31.72B | 24.72% |
| Dec 30, 2022 | 25.43B | -20.73% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,101.56B |
| Genmab | 106.28B |
| Coloplast | 103.91B |
| ALK-Abelló | 49.32B |
| Demant | 39.54B |
| Ambu A/S | 20.05B |
| Zealand Pharma | 16.59B |
| Bavarian Nordic | 14.16B |